Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tatjana Terzic has a total of 230 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of Prognostic Significance of CD47 Expression in Newly Diagnosed Large B Cell Lymphoma

    by Olivera Markovic, Ilija Bukurecki, Anica Divac Pravdic, Gligorije Marinkovic, Tatjana Terzic, Miroslav Pavlovic, Vladimir Nikolic, Nikola Vukosavljevic, Zorica Cvetkovic

    CD47 is a transmembrane protein that possesses the ability to inhibit macrophage phagocytosis, enabling immune system evasion. While CD47 overexpression is associated with a poor prognosis in solid malignancies, data on its prognostic significance in lymphomas are inconsistent. This study aimed to evaluate the clinical and prognostic significance of CD47 expression in patients with large B-cell lymphoma (LBCL). In this study biopsy specimens from 146 patients diagnosed with LBCL and treated with immunochemotherapy were analyzed. CD47 expression was assessed using standard immunohistochemical methods. A high level of CD47 expression was detected in 30 (20.5%) patients. High CD47 expression was more frequently observed in patients with high β2-microglobulin levels and extranodal disease compared to nodal LBCL. No significant difference in CD47 expression was observed between gastrointestinal LBCL and other extranodal localizations. CD47 positivity had no significant influence on progression-free survival (PFS) and overall survival (OS); however, a trend toward shorter PFS and OS was noted (p = 0.099 and p = 0.149, respectively). The median PFS and OS were 27 and 37 months, respectively, in patients with high CD47 expression, while the median PFS and OS were not reached in the group of CD47 negative patients. Although CD47 expression was not an independent predictor of survival, the magnitude and direction of the observed hazard ratios suggest a potentially clinically meaningful effect.

  • Open Access

    Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms

    by Danijela Lekovic, Jelena Ivanovic, Tatjana Terzic, Maja Perunicic Jovanovic, Marija Dencic Fekete, Jelica Jovanovic, Isidora Arsenovic, Vojin Vukovic, Jelena Bila, Andrija Bogdanovic, et al.

    Background: The occurrence of myeloproliferative neoplasms (MPNs) that evolve into each other is well-described, as is this occurrence of lymphoproliferative neoplasms (LPNs). However, less is known about rare MPN/LPN coexistence, and the aim of our study was to analyze charachteristics of these patients after long term follow-up. Methods: Fourteen patients with MPN/LPN coexistence were diagnosed and treated according to guidelines at a single university center across two decades. Results: The overall median age was 53 years (22–69). MPNs patients with subsequent LPNs had a shorter period of second malignancy development and a more aggressive course of LPN, which can cause fatal outcomes. Polycythemia vera and chronic lymphocytic leukemia were most commonly associated (36%). The JAK2V617F mutation had 2/3 and cytogenetic abnormalities occurred in 1/3 of patients. MPN/LPN coexistence cases had significantly higher thrombotic potential (42.8%) and a higher third malignancy accruement frequency (21.4%) versus those without such malignancies. Conclusions: Considering the younger ages at MPN diagnosis, it is recommended to check regularly for blood lymphocytosis or lymphadenopathy occurrences and organomegaly progression faster than expected for MPN, with the aim of timely LPN diagnoses. The presence of molecular-cytogenetic abnormalities in a majority of patients indicate possible genetic instability and increased risk of development of multiple neoplasms, thus elevating thrombotic risk.

  • Open Access

    Gray Level Co-Occurrence Matrix, Fractal and Wavelet Analyses of Discrete Changes in Cell Nuclear Structure following Osmotic Stress: Focus on Machine Learning Methods

    by Igor Pantic, Svetlana Valjarevic, Jelena Cumic, Ivana Paunkovic, Tatjana Terzic, Peter R. Corridon

    In this work, we demonstrate that it is possible to create supervised machine-learning models using a support vector machine and random forest algorithms to separate yeast cells exposed to hyperosmotic stress from intact cells. We performed fractal, gray level co-occurrence matrix (GLCM), and discrete wavelet transform analyses on digital micrographs of nuclear regions of interest of a total of 2000 Saccharomyces cerevisiae cells: 1000 exposed to hyperosmotic environments and 1000 control cells. For each nucleus, we calculated values for fractal dimension, angular second moment, inverse difference moment, textural contrast, correlation feature, textural variance, and discrete wavelet coefficient energy. The support vector machine achieved an acceptable classification accuracy of 71.7% in predicting whether the cell belonged to the experimental or control group. The random forest model performed better than the support vector machine, with a classification accuracy of 79.8%. These findings can serve as a starting point for developing AI-based methods that use GLCM, fractal, and wavelet data to classify damaged and healthy cells and make predictions about various physiological and pathological phenomena associated with osmotic stress.


  • Open Access

    Laparoscopic approach in the treatment of splenic angiolipomatous hamartoma: the first report of a case

    by Vladimir M. Milosavljevic, Boris S. Tadic, Nikola M. Grubor, Milica D. Mitrovic, Miljan S. Ceranic, Borislav L. Toskovic, Tatjana T. Terzic

    Angiolipomatous hamartoma is a benign mesenchymal proliferation of unknown aetiology. Only a few cases have been documented in the published literature. This current case report describes a 57-year-old female patient who was hospitalized for an assessment of a previously radiologically-verified splenic lesion and further treatment. The patient had been surgically treated 10 years previously; a lobectomy of the superior left pulmonary lobe had been performed in order to remove a verified tumour lesion. A complete radiological examination was undertaken, which verified a spleen of a size that was within the physiological range, with a centrally-located lobular tumour lesion. Given the risk of splenic rupture, as well as the fact that the lesion’s aetiology was still undetermined, and finally the fact that differential diagnostics indicated the possibility of a metastasis, the patient was treated surgically. Laparoscopic splenectomy, in the treatment of splenic diseases, even rare ones such as this, is not a novelty. Indeed, it needs to be applied as the standard approach, with the well-known benefits that the minimalized approach offers.

  • Open Access

    Laryngeal dysplasia, state of art

    by Novica Boričić, Tatjana Terzić

    Laryngeal dysplasia is a precancerous lesion of laryngeal epithelium. Cigarette smoking and alcohol consumption have been identified as the two most important etiological risk factors for the development of laryngeal dysplasia. It is considered that low-grade dysplasias have a lower malignant potential and that high-grade dysplasias have a higher potential for progression into squamous cell carcinoma. It is necessary to establish a precise diagnosis to prevent the progression of dysplasia into squamous cell carcinoma. Dysplasia has a diverse macroscopic presentation including leukoplakia, erythroleukoplakia, hyperkeratotic thickening, or exophytic tumor-like masses. Available laryngoscopic techniques are not diagnostically efficient. The diagnosis is based on the histopathological picture of the lesion. There are several classification systems of laryngeal dysplasias that are used in practice, but each relies on the subjective interpretation of morphological criteria. There is great interobserver variability among pathologists for each of the existing dysplasia classifications. All classification systems have weak correlations between the degree of dysplasia and the risk of malignant transformation. So far, there is no biological or genetic marker that is specific for dysplasia or type of laryngeal dysplasia; however, recent studies identified some biomarkers that could be used to determine the malignant potential of dysplasias. The aim of this mini-review is to show the novelties in the classification, etiology, histopathological diagnosis, and therapy of laryngeal dysplasia.

  • Open Access

    Rapid progression to Richter’s syndrome in a patient with chronic lymphocytic leukemia and near-triploid karyotype

    by Marija Dencic-Fekete, Tatjana Terzic, Ljubomir Jakovic, Vladislava Djurasinovic, Teodora Djurasevic-Karan, Milica Radojkovic, Sonja Pavlovic, Andrija Bogdanovic

    Introduction. The presence of aneuploidy in patients with chronic lymphocytic leukemia (CLL), except trisomy 12, is quite uncommon. The frequency of hyperdiploidy or near-tetraploidy ocurrs in 1-3% of the CLL patients and usually confer poor prognosis. Case report. We report a patient in a progressive phase of CLL with near-triploid karyotype. Cytogenetic analysis was performed and complemented with molecular methods and pathohistological examination. The complex karyotype was accompanied with the TP53, C-MYC and IGH gene disruptions, the most probable cause of rapid evolution into Richter's syndrome. Conclusion. Utilization of comprehensive diagnostic techniques is highly recommended in patients with progressive phase of CLL, primarily for the adequate choice of management strategy. The current case confirms poor prognosis of the previously reported CLL patients with aneuploidy.

  • Open Access

    Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma

    by Novica Boricic, Ivan Boricic, Ivan Soldatovic, Jovica Milovanovic, Aleksandar Trivic, Tatjana Terzic

    There are no reliable immunohistochemical markers for diagnosing laryngeal squamous cell carcinoma (SCC) or diagnosing and grading laryngeal dysplasia. We aimed to evaluate the diagnostic utility of CK8, CK10, CK13, and CK17 in benign laryngeal lesions, laryngeal dysplasia, and laryngeal SCC. This retrospective study included 151 patients diagnosed with laryngeal papilloma, laryngeal polyps, laryngeal dysplasia, and laryngeal SCC who underwent surgical treatment between 2010 and 2020. Immunohistochemistry (IHC) was carried out using specific monoclonal antibodies against CK8, CK10, CK13, and CK17. Two experienced pathologists performed semi-quantitative scoring of IHC positivity. The diagnostic significance of the markers was analyzed. CK13 showed a sensitivity of 100% and a specificity of 82.5% for distinguishing between laryngeal SCC and laryngeal dysplasia and benign lesions. CK17 showed a sensitivity of 78.3% and specificity of 57.1% for the detection of laryngeal SCC vs. laryngeal dysplasia. CK10 showed a sensitivity of 80.0% for discriminating between low-grade and high-grade dysplasia, and a specificity of 61.1%. Loss of CK13 expression is a reliable diagnostic tool for diagnosing laryngeal lesions with malignant potential and determining resection lines. In lesions with diminished CK13 expression, CK17 could be used as an auxiliary immunohistochemical marker in diagnosing laryngeal SCC. In CK13-negative and CK17-positive lesions, CK10 positivity could be used to determine low-grade dysplasia. CK8 is not a useful IHC marker in differentiating between benign laryngeal lesions, laryngeal dysplasia, and laryngeal SCC.


    • 26 March 2022

    Autopsy Of Two Patients Previously Diagnosed with COVID-19

    by Svetislav Tatić, Dimitrije Brašanac, Dejan Oprić, Jelena Sopta, Tatjana Terzic, Nada Tomanović, Sanja Radojević-Škodrić, Ljiljana Bogdanović, Sofija Glumac, Emilija Manojlović-Gačić

    • 1 January 2022

    Praktikum sa radnom sveskom za histopatološke vežbe

    by Tatjana Terzic, Dimitrije Č Brašanac, Tatjana Terzić, Sofija Glumac, Radmila Janković, Maja Životić